US Stock MarketDetailed Quotes

RPHM Reneo Pharmaceuticals

Watchlist
  • 1.670
  • +0.020+1.21%
Close Apr 26 16:00 ET
  • 1.670
  • 0.0000.00%
Post 16:20 ET
55.81MMarket Cap-662P/E (TTM)

Reneo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
54.24%83.05M
71.72%25.01M
50.92%20.89M
69.25%21.04M
23.88%16.12M
35.24%53.85M
37.07%14.56M
8.53%13.84M
34.71%12.43M
80.41%13.02M
Selling and administrative expenses
63.79%26.44M
76.03%7.4M
86.21%7.27M
54.43%6.64M
37.33%5.13M
38.58%16.14M
19.32%4.21M
13.63%3.9M
45.78%4.3M
114.52%3.74M
-General and administrative expense
63.79%26.44M
76.03%7.4M
86.21%7.27M
54.43%6.64M
37.33%5.13M
38.58%16.14M
19.32%4.21M
13.63%3.9M
45.78%4.3M
114.52%3.74M
Research and development costs
50.15%56.61M
69.97%17.6M
37.07%13.62M
77.08%14.4M
18.46%10.99M
33.85%37.71M
45.87%10.36M
6.65%9.94M
29.51%8.13M
69.55%9.28M
Operating profit
-54.24%-83.05M
-71.72%-25.01M
-50.92%-20.89M
-69.25%-21.04M
-23.88%-16.12M
-35.24%-53.85M
-37.07%-14.56M
-8.53%-13.84M
-34.71%-12.43M
-80.41%-13.02M
Net non-operating interest income expense
Other net income (expense)
199.26%5.67M
50.94%1.45M
103.12%1.69M
1,167.23%1.51M
4,938.10%1.02M
3,843.75%1.89M
5,558.82%962K
4,800.00%833K
891.67%119K
-1,150.00%-21K
Other non- operating income (expenses)
199.26%5.67M
50.94%1.45M
103.12%1.69M
1,167.23%1.51M
4,938.10%1.02M
3,843.75%1.89M
5,558.82%962K
4,800.00%833K
891.67%119K
-1,150.00%-21K
Income before tax
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
Income tax
Net income
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
Net income continuous Operations
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
Minority interest income
Net income attributable to the parent company
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.95%-77.39M
-73.19%-23.55M
-47.58%-19.2M
-58.63%-19.53M
-15.89%-15.11M
-30.64%-51.96M
-28.22%-13.6M
-2.14%-13.01M
-33.59%-12.31M
-80.75%-13.04M
Basic earnings per share
-18.87%-2.52
-26.79%-0.71
-7.55%-0.57
-30.00%-0.65
-13.21%-0.6
3.20%-2.12
-30.23%-0.56
-1.92%-0.53
-16.28%-0.5
-77.92%-0.53
Diluted earnings per share
-18.87%-2.52
-26.79%-0.71
-7.55%-0.57
-30.00%-0.65
-13.21%-0.6
3.20%-2.12
-30.23%-0.56
-1.92%-0.53
-16.28%-0.5
-77.92%-0.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 54.24%83.05M71.72%25.01M50.92%20.89M69.25%21.04M23.88%16.12M35.24%53.85M37.07%14.56M8.53%13.84M34.71%12.43M80.41%13.02M
Selling and administrative expenses 63.79%26.44M76.03%7.4M86.21%7.27M54.43%6.64M37.33%5.13M38.58%16.14M19.32%4.21M13.63%3.9M45.78%4.3M114.52%3.74M
-General and administrative expense 63.79%26.44M76.03%7.4M86.21%7.27M54.43%6.64M37.33%5.13M38.58%16.14M19.32%4.21M13.63%3.9M45.78%4.3M114.52%3.74M
Research and development costs 50.15%56.61M69.97%17.6M37.07%13.62M77.08%14.4M18.46%10.99M33.85%37.71M45.87%10.36M6.65%9.94M29.51%8.13M69.55%9.28M
Operating profit -54.24%-83.05M-71.72%-25.01M-50.92%-20.89M-69.25%-21.04M-23.88%-16.12M-35.24%-53.85M-37.07%-14.56M-8.53%-13.84M-34.71%-12.43M-80.41%-13.02M
Net non-operating interest income expense
Other net income (expense) 199.26%5.67M50.94%1.45M103.12%1.69M1,167.23%1.51M4,938.10%1.02M3,843.75%1.89M5,558.82%962K4,800.00%833K891.67%119K-1,150.00%-21K
Other non- operating income (expenses) 199.26%5.67M50.94%1.45M103.12%1.69M1,167.23%1.51M4,938.10%1.02M3,843.75%1.89M5,558.82%962K4,800.00%833K891.67%119K-1,150.00%-21K
Income before tax -48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M-80.75%-13.04M
Income tax
Net income -48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M-80.75%-13.04M
Net income continuous Operations -48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M-80.75%-13.04M
Minority interest income
Net income attributable to the parent company -48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M-80.75%-13.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.95%-77.39M-73.19%-23.55M-47.58%-19.2M-58.63%-19.53M-15.89%-15.11M-30.64%-51.96M-28.22%-13.6M-2.14%-13.01M-33.59%-12.31M-80.75%-13.04M
Basic earnings per share -18.87%-2.52-26.79%-0.71-7.55%-0.57-30.00%-0.65-13.21%-0.63.20%-2.12-30.23%-0.56-1.92%-0.53-16.28%-0.5-77.92%-0.53
Diluted earnings per share -18.87%-2.52-26.79%-0.71-7.55%-0.57-30.00%-0.65-13.21%-0.63.20%-2.12-30.23%-0.56-1.92%-0.53-16.28%-0.5-77.92%-0.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg